Posts tagged “Local Firms”
Drug giant GlaxoSmithKline, hurt in part by a 20 percent decline in sales in China where the company is under criminal investigation, reports revenues and earnings that missed analysts' expectations on Wednesday. GSK also reduced its growth forecast for 2014 from as much as 8 percent to "basically similar" to 2013 and says it can't estimate what the financial impact could be from the China case.
Even with sales and profits declining sharply from a year ago, a cut in a growth forecast for this year and continuing legal issues resulting from a criminal investigation in China, GSK's chief executive officer Andrew Witty puts a positive spin on the state of the company in a video interview.
Comcast on Tuesday beat Street estimates for earnings with high-speed Internet customer growth leading the way; meanwhile, Comcast updates Time Warner acquisition; in other news, Verizon earnings soar.
Sprout Pharmaceuticals has positioned its drug as the first female equivalent to Viagra. And the privately held firm has turned to scores of investors for financial help in driving the drug toward FDA approval.
This is part one of a three-part series on how to turn ideas into companies. This story features Scot Wingo, co-founder and CEO of ChannelAdvisor, and is part the news partnership between WRAL TechWire and ExitEvent.
Under a three-year award from the U.S. Department of Energy, researchers at RTI International are looking at the cost-competitive production of hydrocarbon transportation fuels for less than $3 per gallon.
Nearly the entire staff of the Xbox Entertainment Studios division is being let go as part of Microsoft's huge announced job layoffs. So does this mean now live action video for the "gears of War" franchise Microsoft acquired from Cary-based Epic Games earlier this year? WRAL TechWire Insider John Gaudiosi reports exclusively for Insider subscribers.
Some local websites run one or two tech stories per day. Others a few more but mixed with a variety of business news. At WRAL TechWire, tech and life science make up the menu with nearly 50 stories published over the last five business days. Here's a look back at technology, life science and other related news as reported in WRAL TechWire last week.
Startup says aloha to name after Hawaii protests; FDA-Pozen update; new Tantalus exec; Apple $400M ebook settlement; Novartis earnings; Visa's new system
In today's Bulldog wrapup of life science and technology news: A L.A. company changes its name after protests in Hawaii; FDA accepts Pozen application; smart grid firm Tantalus in Raleigh names COO; Apple faces $400M ebook settlement; Novartis earnings; and Visa launches new online payment system.
If Lenovo has a "parent" in its rise as a global technology powerhouse, it's IBM. After all, Big Blue's sale of its PC division to Lenovo in 2005 took the China-born company international. Now, Lenovo is trying to buy IBM's x86 server business and Google's Motorola Mobility to accelerate growth in servers and smartphones. So what does IBM do as Lenovo grows as a threat to Apple? The Skinny talks with an analyst about IBM's big deal with Apple. Is it a slap in the face to Lenovo? By the way, BlackBerry already is caught up in fallout from the deal.
TyraTech is rolling out its head lice product in the U.K. and is funding its European expansion with $6 million in new funding. The company, which moved to Morrisville in 2011, says the head lice market is a $150 million a year opportunity.
Chimerix, the Durham-based drug company working on experimental medicine that could save the life of a seven-year-old Josh Hardy, was granted approval by the U.S. Food and Drug Administration to administer the drug to the boy in March. On Wednesday, his mother said he is doing well and going home.
Yahoo earnings fall; N.C. Solar Center's new name; Novartis-Google 'Glass' contacts; Cree expands; Sling's new devices
In today's Bulldog wrapup of technology and life science news: Yahoo takes a hit; N.C. Solar Center gets a new name; Novartis teams with Google for "Glass" contacts; Cree adds space; Sling's new devices.
GlaxoSmithKline, which operates a huge drug manufacturing facility in Zebulon, is investing as much as $25 million to license a technology platform from a California firm as part of efforts to develop new drugs. But GSK isn't bringing the platform to N.C., at least initially.
Researchers at Cloud Pharmaceuticals said Monday that they have been granted 1 million hours of use on the IBM Blue Gene/Q Supercomputer for computational drug design and discovery to target orphan diseases including Malaria at Argonne National Laboratory.
The Council for Entrepreneurial Development's Tech Venture Demo and Showcase deadline to apply is this Thursday.